Assessing lung function and exercise capacity in COVID-19 patients
Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
This study looks at how well people who have recovered from COVID-19 can breathe and exercise over two years, while also checking how their immune systems respond to the virus and vaccines.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT04611243 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate lung function, exercise capacity, and quality of life in patients who have recovered from COVID-19 over a two-year period. It will also investigate the longevity of serological responses to SARS-CoV-2 and the effectiveness of different COVID-19 vaccines in generating immune responses. Participants will undergo various assessments, including lung function tests and blood sample collection, at multiple time points post-discharge. The study will include both convalescent patients and vaccinated individuals to understand the immune response dynamics.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who have been discharged from the hospital after treatment for COVID-19.
Not a fit: Patients who are unwilling to participate in follow-up assessments will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the long-term effects of COVID-19 and the effectiveness of vaccines, ultimately improving patient care and treatment strategies.
How similar studies have performed: Other studies have shown success in assessing long-term effects of COVID-19, but this study's specific approach to evaluating immune responses and exercise capacity is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients who have been discharged from hospital following treatment for COVID-19 - Exclusion Criteria: Unwilling to be follow up \-
Where this trial is running
Hong Kong
- Prince of Wales Hospital — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: David S Hui, MD — Chinese University of Hong Kong
- Study coordinator: Susanna Ng, MBChB
- Email: drsssng@gmail.com
- Phone: 85235053128
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.